Clinical trial
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® ; Cartilage Defect Treatment Assisting Cartilage Regeneration in Knee Cartilage Defects : Multicenter, Independent Evaluator and Subject Blinded, Microfracture Comparative, Superiority, Randomized, Confirmatory Clinical Study and 5 Years Follow up Study
NCT05440370 is registered in ClinicalTrials.gov with L&C Bio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® ; Cartilage Defect Treatment Assisting Cartilage Regeneration in Knee Cartilage Defects : Multicenter, Independent Evaluator and Subject Blinded, Microfracture Comparative, Superiority, Randomized, Confirmatory Clinical Study and 5 Years Follow up Study
- Lead sponsor
- L&C Bio
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 16, 2020
- Completion date
- January 31, 2027
- Enrollment
- 90 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.